Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data | BMC Psychiatry BioMed Central Research article Psychotropic medication in the French child and adolescent population prevalence estimation from health insurance data and national self-report survey data Eric Acquaviva 1 2 3 Stéphane Legleye1 2 4 Guy R Auleley5 Jean Deligne6 Didier Carel7 and Bruno Falissard B1 2 8 Open Access Address 1Inserm U669 PSIGIAM Paris France 2Université Paris-Sud UMR-S0669 Paris France 3Hôpital Robert Debré Service de psychiatrie Paris France 4Observatoire Fran ais des Drogues et toxicomanies Saint Denis France 5Caisse Nationale du RSI La Plaine-Saint Denis France 6Régime Social des Indépendants Nord - Pas de Calais Lille France 7Urcam de Franche-Comté Besanẹon France and 8Hôpital Paul Brousse Département de santé publique Villejuif France Email Eric Acquaviva - dracquaviva@ Stéphane Legleye - stleg@ Jean Deligne - Didier Carel - dcarel@ Bruno Falissard B - falissard-b@ Corresponding author Published 17 November 2009 Received 30 June 2009 Accepted 17 November 2009 BMC Psychiatry 2009 9 72 doi 86 I47I-244X-9-72 p This article is available from http 1471-244X 9 72 2009 Acquaviva et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background The aim of this work is to estimate the French frequencies of dispensed psychotropic prescriptions in children and adolescents. Prevalence estimations of dispensed prescriptions are compared to the frequencies of use of psychotropic reported by I7 year-old adolescents. Methods Prescription data is derived from national health insurance .
